International Journal of Cancer
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
International Journal of Cancer: Preface
1999
-
A postscript to the international workshop on assessing health-related quality of life in children with cancer
1999
-
Birth characteristics and the risk of childhood brain tumors: A case-control study in Ontario, Canada..
156:1909-1915.
2025
-
Therapeutic targeting of chromatin alterations in leukemia and solid tumors.
2025
-
Modern era systemic therapies: Expanding concepts of cure in early and locally advanced non‐small cell lung cancer.
155:963-978.
2024
-
Childhood head trauma and the risk of childhood brain tumours: A case‐control study in Ontario, Canada.
150:795-801.
2022
-
Cancer incidence in relation to body fatness among 0.5 million men and women: Findings from the China Kadoorie Biobank.
146:987-998.
2020
-
Final results from GCIG/ENGOT/AGO‐OVAR 12, a randomised placebo‐controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer.
146:439-448.
2020
-
Assessing the time dependence of prognostic values of cytology and human papillomavirus testing in cervical cancer screening.
144:2408-2418.
2019
-
The association between smoking and cancer incidence in BRCA1 and BRCA2 mutation carriers.
142:2263-2272.
2018
-
BRM polymorphisms, pancreatic cancer risk and survival.
139:2474-2481.
2016
-
Human papillomavirus testing versus cytology in primary cervical cancer screening: End‐of‐study and extended follow‐up results from the Canadian cervical cancer screening trial.
139:2456-2466.
2016
-
Impact of registration on clinical trials on infection risk in pediatric acute myeloid leukemia.
138:1785-1791.
2016
-
Increasing participation in colorectal cancer screening: Results from a cluster randomized trial of directly mailed gFOBT kits to previous nonresponders.
136:E697-E703.
2015
-
Novel function of Oncostatin M as a potent tumour‐promoting agent in lung.
136:831-843.
2015
-
S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia.
134:1379-1388.
2014
-
Feasibility of real time next generation sequencing of cancer genes linked to drug response: Results from a clinical trial.
132:1547-1555.
2013
-
Phytoestrogen intake from foods, during adolescence and adulthood, and risk of breast cancer by estrogen and progesterone receptor tumor subgroup among Ontario women.
132:1683-1692.
2013
-
Use of isoflavone supplements is associated with reduced postmenopausal breast cancer risk.
132:1439-1450.
2013
-
The APTIMA HPV assay versus the hybrid capture 2 test in triage of women with ASC‐US or LSIL cervical cytology: A meta‐analysis of the diagnostic accuracy.
132:101-108.
2013
-
Single nucleotide polymorphisms in the matrix metalloproteinase gene family and the frequency and duration of gastroesophageal reflux disease influence the risk of esophageal adenocarcinoma.
131:2478-2486.
2012
-
Surveillance and survival among adolescents and young adults with cancer in Ontario, Canada.
131:2660-2667.
2012
-
Neuropeptide Y stimulates proliferation and migration in the 4T1 breast cancer cell line.
131:276-286.
2012
-
Prospective study on the role of glucose metabolism in breast cancer occurrence.
130:921-929.
2012
-
Parents of children with cancer: Which factors explain differences in health‐related quality of life.
129:1190-1198.
2011
-
Direct anti‐cancer effect of oncostatin M on chondrosarcoma.
128:1822-1835.
2011
-
Quality of life during active treatment for pediatric acute lymphoblastic leukemia.
128:1213-1220.
2011
-
Determinants of delays in treatment initiation in children and adolescents diagnosed with leukemia or lymphoma in Canada.
126:1936-1943.
2010
-
Prevalence and predictors of abandonment of therapy among children with cancer in El Salvador.
125:2144-2146.
2009
-
The methylenetetrahydrofolate reductase C677T mutation induces cell‐specific changes in genomic DNA methylation and uracil misincorporation: A possible molecular basis for the site‐specific cancer risk modification.
124:1999-2005.
2009
-
Prevalence and frequency of circulating t(14;18)-MBR translocation carrying cells in healthy individuals.
124:958-963.
2009
-
Autocrine VEGF‐A/KDR loop protects epithelial ovarian carcinoma cells from anoikis.
124:553-561.
2009
-
Targeting prostate cancer with HTI‐286, a synthetic analog of the marine sponge product hemiasterlin.
122:2368-2376.
2008
-
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.
122:2017-2022.
2008
-
The molecular etiology of breast cancer: Evidence from biomarkers of risk.
122:1949-1957.
2008
-
Salad vegetables dietary pattern protects against HER‐2‐positive breast cancer: A prospective Italian study.
121:911-914.
2007
-
Lifetime adult weight gain, central adiposity, and the risk of pre‐ and postmenopausal breast cancer in the Western New York exposures and breast cancer study.
119:2931-2937.
2006
-
Circulating enterolactone and risk of endometrial cancer.
119:2376-2381.
2006
-
Erratum.
119:2503-2503.
2006
-
Adenosine upregulates CXCR4 and enhances the proliferative and migratory responses of human carcinoma cells to CXCL12/SDF‐1α.
119:2044-2053.
2006
-
Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: Design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
119:615-623.
2006
-
Incidence trends and projections for childhood cancer in Ontario.
118:2809-2815.
2006
-
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: An update.
118:2281-2284.
2006
-
Serum testosterone levels and breast cancer recurrence.
113:499-502.
2005
-
Endogenous sex hormones and subsequent breast cancer in premenopausal women.
112:312-318.
2004
-
Dietary lignan intakes and risk of pre- and postmenopausal breast cancer..
111:440-443.
2004
-
Dietary lignan intakes and risk of pre‐ and postmenopausal breast cancer.
111:440-443.
2004
-
Hypoxia‐inducible factor‐1α in non small cell lung cancer: Relation to growth factor, protease and apoptosis pathways.
111:43-50.
2004
-
Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women.
108:425-432.
2004
-
Prediagnostic levels of C‐peptide, IGF‐I, IGFBP ‐1, ‐2 and ‐3 and risk of endometrial cancer.
108:262-268.
2004
-
Estradiol increases extracellular levels of vascular endothelial growth factor in vivo in murine mammary cancer.
107:535-540.
2003
-
Childhood cancer registries in Ontario, Canada: Lessons learned from a comparison of two registries.
105:88-91.
2003
-
Photodynamic therapy with Pd‐bacteriopheophorbide (TOOKAD): Successful in vivo treatment of human prostatic small cell carcinoma xenografts.
104:782-789.
2003
-
Circulating levels of sex steroid hormones and risk of ovarian cancer.
104:636-642.
2003
-
Circulating levels of insulin‐like growth factor‐I and risk of ovarian cancer.
101:549-554.
2002
-
Body mass index in relation to ovarian cancer: A multi‐centre nested case‐control study.
99:603-608.
2002
-
Herceptest: Her2 expression and gene amplification in non-small cell lung cancer.
92:480-483.
2001
-
Quantification of matrix metalloproteinase activity in plasma of patients enrolled in a BAY 12-9566 phase I study.
91:857-862.
2001
-
The spectrum of HIV-1 related cancers in South Africa.
88:489-492.
2000
-
Preface.
83:1-1.
1999
-
Insulin-like growth factor–binding protein-3 and breast cancer survival.
79:624-628.
1998
-
Quantitative analysis of p53 protein in non-small cell lung cancer and its prognostic value.
79:494-501.
1998
-
Immunofluorometrically determined p53 accumulation as a prognostic indicator in italian breast cancer patients.
79:147-152.
1998
-
Non-Hodgkin's lymphoma among people with AIDS: Incidence, presentation and public health burden.
73:645-650.
1997
-
Erratum: Kaposi's sarcoma and non-Hodgkin's lymphoma following the diagnosis of AIDS.Int. J. Cancer, 68, 754–758 (1996).
70:727-727.
1997
-
Moving promising research findings to the clinic: Methodological issues in the design and conduct of clinical trials of retinoids.
70:467-469.
1997
-
Apoptosis and other effects of radiation in normal human urothelial cells.
5:150-153.
1997
-
Delayed expression of lethal mutations and genomic instability in the progeny of human epithelial cells that survived in a bystander-killing environment.
5:106-110.
1997
-
Potential indicators of radiosensitivity in squamous cell carcinoma of the head and neck.
5:180-186.
1997
-
Radiation-induced carcinogenesis:Studies using human epithelial cell lines.
5:139-143.
1997
-
Risk of cutaneous melanoma associated with a family history of the disease.
62:377-381.
1995
-
Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: Systematic overview of 10 case‐control studies.
62:367-376.
1995
-
Extended abstract: Unlimited life span of human diploid normal epithelial cells.
3:363-367.
1995
-
Individual variation in the expression of proteins involved in the regulation of growth and apoptosis post‐DNA damage in normal human urothelium.
3:404-407.
1995
-
Counteracting effects of dexamethasone and α2‐macroglobulin on inhibition of proliferation of normal and neoplastic rat hepatocytes by transforming growth factors‐β type 1 and type 2.
47:311-316.
1991
-
Relative tumorigenicities of hybrid cells with and without hsr‐bearing chromosomes from a human melanoma cell line.
44:360-366.
1989
-
Herpes simplex virus type 2 and human papillomavirus type 16 in cervicitis, dysplasia and invasive cervical carcinoma.
35:51-57.
1985
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)